← Leaderboards
Sandra S Werbel
Wake Forest University
$155,200
Attributed
$155,200
Total exposure
7
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$155,200 · 7
By mechanism
M01$155,200 · 7
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University
Same institution · by research overlap
- Daniel B Kim-Shapiro$10,363,938
- Donald W. Bowden$36,211,199
- Lynne E Wagenknecht$31,529,016
- S Bruce King$4,059,596
- David M Reboussin$30,919,688
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationDiabetes Mellitus TherapyHuman SubjectInsulinClinical ResearchInhalation Drug AdministrationDrug Administration RoutesNoninsulin Dependent Diabetes MellitusHormone TherapyInsulin Dependent Diabetes MellitusDrug Screening /EvaluationDosage FormsPancreatic IsletsPrediabetic StateAntibody TiteringSulfonylureaAutoantibodyClinical TrialsCombination ChemotherapyDiabetes Mellitus GeneticsDisease /Disorder Prevention /ControlDisease /Disorder Proneness /RiskDosageGlucose Tolerance Test
Grant awards (14)
INHALED VS SUBCUTANEOUS INTENSIVE INSULIN IN NIDDM$0
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL$0
M01 · FY2002 · RR
INHALED HUMAN INSULIN VS USUAL SQ INSULIN IN TYPE I DIABETES MELLITUS$0
M01 · FY2002 · RR
INHALED HUMAN INSULIN VS USUAL SQ INSULIN IN TYPE II DIABETES MELLITUS$0
M01 · FY2002 · RR
INHALED HUMAN INSULIN AS ADJUNCTIVE THERAPY IN SUBJECTS WITH TYPE 2 DIABETES$0
M01 · FY2002 · RR
INHALED VS SUBCUTANEOUS INSULIN IN TYPE I DIABETES$0
M01 · FY2002 · RR
INHALED VS SUBCUTANEOUS HUMAN INSULIN IN TYPE II DIABETE$0
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL$38,800
M01 · FY2000 · RR
INHALED HUMAN INSULIN VS USUAL SQ INSULIN IN TYPE I DIABETES MELLITUS$38,800
M01 · FY2000 · RR
INHALED HUMAN INSULIN VS USUAL SQ INSULIN IN TYPE II DIABETES MELLITUS$38,800
M01 · FY2000 · RR
INHALED HUMAN INSULIN AS ADJUNCTIVE THERAPY IN SUBJECTS WITH TYPE 2 DIABETES$38,800
M01 · FY2000 · RR
INHALED VS SUBCUTANEOUS INSULIN IN TYPE I DIABETES$0
M01 · FY2000 · RR
INHALED VS SUBCUTANEOUS HUMAN INSULIN IN TYPE II DIABETE$0
M01 · FY2000 · RR
INHALED VS SUBCUTANEOUS INTENSIVE INSULIN IN NIDDM$0
M01 · FY2000 · RR